QuantumPharm, Inc. (2228) Price & Analysis

Compare

10 Followers

2228 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$3.05 - HK$14.18

Previous CloseN/A

Volume31.51M

Average Volume (3M)253.40M

Market Cap

HK$43.18B

Enterprise ValueHK$15.51B

Total Cash (Recent Filing)HK$3.39B

Total Debt (Recent Filing)HK$163.57M

Price to Earnings (P/E)―

Beta0.78

Next Earnings

Mar 27, 2026

EPS EstimateN/A

Last Dividend Ex-Date

Jun 13, 2016

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares Outstanding4,302,922,000

10 Day Avg. Volume150,001,594

30 Day Avg. Volume253,404,505

Financial Highlights & Ratios

PEG Ratio0.00

Price to Book (P/B)2.72

Price to Sales (P/S)40.47

P/FCF Ratio-20.09

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$10.50

Price Target Upside6.28% Upside

Rating ConsensusHold

Number of Analyst Covering1

Bulls Say, Bears Say

Bulls Say

Revenue GrowthXtalPi leverages its proprietary AI-powered R&D platform to deliver stable and accelerating revenue growth across two core business areas: drug discovery and intelligent robotics.

Strategic PartnershipsXtalPi's expanding ecosystem of partnerships reflects its strong commercialization potential across AI and robotics-enabled industries.

Bears Say

R&D Pipeline RisksRisks include potential delays in partnered R&D pipelines, uncertainty in commercialization sustainability, and possible sell-off following lock-up expiry.

QuantumPharm, Inc. News

XtalPi Holdings Clarifies Interim Results, Corrects Earnings Figures

An update from QuantumPharm, Inc. ( ($HK:2228) ) is now available. XtalPi Holdings Limited, a company listed on...

2d ago

2228

XtalPi Completes Successful Share Placement to Fund Technological Advancements

The latest update is out from QuantumPharm, Inc. ( ($HK:2228) ). XtalPi Holdings Limited has successfully completed the...

14d ago

2228

XtalPi Holdings Announces New Share Placement to Raise HK$2.63 Billion

QuantumPharm, Inc. ( ($HK:2228) ) has shared an announcement. XtalPi Holdings Limited, a company incorporated in the Cayman...

21d ago

2228

XtalPi Reports Record Revenue Growth and Profitability in H1 2025

An announcement from QuantumPharm, Inc. ( ($HK:2228) ) is now available. XtalPi Holdings Limited, a company incorporated in...

22d ago

2228

XtalPi Holdings Announces Upcoming Board Meeting for Interim Results

QuantumPharm, Inc. ( ($HK:2228) ) has shared an update. XtalPi Holdings Limited, a company incorporated in the Cayman...

1M ago

2228

XtalPi Holdings Announces Significant Financial Turnaround in H1 2025

The latest announcement is out from QuantumPharm, Inc. ( ($HK:2228) ). XtalPi Holdings Limited, a company incorporated in...

1M ago

2228

XtalPi and DoveTree Enter Definitive Agreement for AI-Driven Drug Discovery

QuantumPharm, Inc. ( ($HK:2228) ) has shared an announcement. XtalPi Holdings Limited, through its subsidiary Shenzhen XtalPi Technology...

1M ago

2228

XtalPi Partners with DoveTree for AI-Driven Drug Discovery

An update from QuantumPharm, Inc. ( ($HK:2228) ) is now available. XtalPi Holdings Limited has entered into a...

3M ago

2228

XtalPi Co-Founders Extend Lock-Up, Signaling Confidence

QuantumPharm, Inc. ( ($HK:2228) ) just unveiled an update. XtalPi Holdings Limited, a company incorporated in the Cayman...

4M ago

2228

XtalPi Holdings Acquires 90% Stake in Target Company for RMB250 Million

The latest update is out from QuantumPharm, Inc. ( ($HK:2228) ). XtalPi Holdings Limited, a company incorporated in...

4M ago

2228

2228 FAQ

What was QuantumPharm, Inc.’s price range in the past 12 months?

QuantumPharm, Inc. lowest stock price was HK$3.05 and its highest was HK$14.18 in the past 12 months.

What is QuantumPharm, Inc.’s market cap?

QuantumPharm, Inc.’s market cap is HK$43.18B.

When is QuantumPharm, Inc.’s upcoming earnings report date?

QuantumPharm, Inc.’s upcoming earnings report date is Mar 27, 2026 which is in 190 days.

How were QuantumPharm, Inc.’s earnings last quarter?

QuantumPharm, Inc. released its earnings results on Aug 27, 2025. The company reported HK$0.016 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.016.

Is QuantumPharm, Inc. overvalued?

According to Wall Street analysts QuantumPharm, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does QuantumPharm, Inc. pay dividends?

QuantumPharm, Inc. pays a Notavailable dividend of HK$0.007 which represents an annual dividend yield of N/A. See more information on QuantumPharm, Inc. dividends here

What is QuantumPharm, Inc.’s EPS estimate?

QuantumPharm, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does QuantumPharm, Inc. have?

QuantumPharm, Inc. has 4,302,922,000 shares outstanding.

What happened to QuantumPharm, Inc.’s price movement after its last earnings report?

QuantumPharm, Inc. reported an EPS of HK$0.016 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.676%.

Which hedge fund is a major shareholder of QuantumPharm, Inc.?

Currently, no hedge funds are holding shares in HK:2228

QuantumPharm, Inc. Stock Smart Score

Underperform

Fundamentals

Return on Equity

-3.55%

Trailing 12-Months

Asset Growth

76.34%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

QuantumPharm, Inc.

QuantumPharm, Inc. (2228) is a leading biotechnology company specializing in the development and commercialization of innovative pharmaceutical solutions. The company focuses on leveraging quantum computing and advanced molecular modeling to accelerate drug discovery and development processes. QuantumPharm's core products include a pipeline of proprietary therapeutics targeting rare and complex diseases, as well as offering strategic partnerships for technology licensing and collaborative research initiatives.

QuantumPharm, Inc. (2228) Earnings & Revenues

Historic Earnings Reports

2228 Stock 12 Month Forecast

Average Price Target

HK$10.50

▲(6.28% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"HK$3","8":"HK$8","13":"HK$13","5.5":"HK$5.5","10.5":"HK$10.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$10.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$10.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$10.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,5.5,8,10.5,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Oct<br/>2024","9":"Apr<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.7,6.069230769230769,6.438461538461539,6.8076923076923075,7.176923076923077,7.546153846153846,7.915384615384616,8.284615384615385,8.653846153846153,9.023076923076923,9.392307692307693,9.76153846153846,10.13076923076923,{"y":10.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.7,6.069230769230769,6.438461538461539,6.8076923076923075,7.176923076923077,7.546153846153846,7.915384615384616,8.284615384615385,8.653846153846153,9.023076923076923,9.392307692307693,9.76153846153846,10.13076923076923,{"y":10.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.7,6.069230769230769,6.438461538461539,6.8076923076923075,7.176923076923077,7.546153846153846,7.915384615384616,8.284615384615385,8.653846153846153,9.023076923076923,9.392307692307693,9.76153846153846,10.13076923076923,{"y":10.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.4,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.4,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.4,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.4,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.28,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.28,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.3,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.98,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.89,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.48,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.81,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.7,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >